FDANonrulemakingFDA-2025-N-2976
Who commented on this docket
Improving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine; Public Workshop; Request for Comments
2 organizations filed 2 public comments on Improving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine; Public Workshop; Request for Comments, at the Food and Drug Administration. The comment window closed 193d ago.
Organizations
2
Comments
2
RIN
—
Comment window
closed 193d ago
Abstract
Open
Commenters (2)
- American Pharmacists Association (APhA)trade assoc.1 filing · confidence 97%
- University of Chicago- Section of Allergy & Immunologyunverified attribution1 filing · confidence 70%
Attribution is name-based and imperfect. regulations.gov data is public record.